The Latest Breaking News from Jazz

The Jazz's new purple and white jerseys should have never gone away.

The biotech industry's prospects look promising due to the use of advanced technologies like AI and VR for research, the growing popularity of tailored treatments and biotech devices, a rise in chronic diseases, and increased R&D spending. Therefore, investors could consider buying biotech stocks Innoviva (INVA), Halozyme Therapeutics (HALO), Jazz…

Rudy Gobert has finally found a place where he's appreciated.

The Utah star's stock has exploded since 2022.

Bradley will join the Utah Jazz front office helmed by Jazz team president Danny Ainge, who drafted Bradley for the Celtics.

The biotechnology industry is expected to grow rapidly due to rising demand for personalized medicines, increased R&D spending, and the adoption of AI in the biopharma market. Hence, quality biotech stocks Incyte (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) could be poised for breakthroughs this month. Read more….

The rookie knocked down a one-footed triple at the first quarter buzzer against the Jazz on Sunday.

The Warriors will be without their All-Star point guard on Sunday against the Jazz.

After missing six games due to a knee injury, Jonathan Kuminga is set to return to the court on Sunday against the Utah Jazz.